Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Rank in Stocks #41091
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Share Price
$0.0202
Last synced: 2024-11-19
Market Cap
$44.67K
Change (1 day)
-0.49%
Change (1 year)
0.00%
Country
IL
Trade Notable Labs, Ltd. (NTBL)

Category

P/E ratio for Notable Labs, Ltd. (NTBL)
P/E ratio as of August 2026 TTM: -0.05
According to Notable Labs, Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.05. At the end of 2022 the company had a P/E ratio of -0.65.
P/E ratio history for Notable Labs, Ltd. from 2015 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) -0.05 -86.68%
2023 -0.37 -43.36%
2022 -0.65 -99.79%
2021 -313.78 127.40%
2020 -137.98 26.10%
2019 -109.42 99.99%
2018 -54.71 -91.85%
2017 -671.58 153.53%
2016 -264.89 5.47%
2015 -251.14 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
28.05 -56,992.90%
US
31.14 -63,272.82%
NL
- -
CH
- -
KR
19.30 -39,245.44%
BE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.